Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04702529 · ClinicalTrials.gov registry record · NA
Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device
A NA study, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04702529: Completed NA study, sponsored by Soliton.
NCT04702529 is a NA study that has completed, run by Soliton. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04702529, a NA study, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A multi-treatment proof of concept clinical study is to evaluate the safety, and efficacy of multiple treatments with Soliton's Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars
Primary Outcome
Incidence of unexpected adverse events and serious adverse events directly attributable to the RAP device or treatment will be reported
Interventions
- DEVICE Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-06-22 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
What the finished NCT04702529 record still lists
NCT04702529 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device) is the first listed.
NCT04702529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04702529 about?
NCT04702529 is a clinical study titled "Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device". A multi-treatment proof of concept clinical study is to evaluate the safety, and efficacy of multiple treatments with Soliton's Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars
What is the current status of trial NCT04702529?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-06-22. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04702529?
The interventions under investigation include: Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device) (DEVICE).
Who is sponsoring clinical trial NCT04702529?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04702529's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI